Valuation : Cenra Inc.

Market Cap 4.98B 158M 136M 128M 116M 218M 14.87B 219M 1.51B 585M 7.63B 591M 579M 24.58B P/E 2024
15.1x
P/E 2025 14x
Enterprise Value 7.24B 229M 197M 185M 169M 317M 21.61B 317M 2.19B 850M 11.09B 859M 841M 35.71B EV / Sales 2024
0.9x
EV / Sales 2025 0.83x
Free-Float
61.49%
Yield 2024
2.72%
Yield 2025 3.01%
1 day-0.73%
1 week-2.15%
Current month-2.01%
1 month+6.07%
3 months-4.21%
6 months+1.49%
Current year+2.10%
1 week 33.8
Extreme 33.8
34.95
1 month 33.8
Extreme 33.8
37.65
Current year 31.55
Extreme 31.55
37.65
1 year 31.55
Extreme 31.55
37.65
3 years 29
Extreme 29
44.55
5 years 29
Extreme 29
44.55
10 years 29
Extreme 29
44.55
Manager TitleAgeSince
Chief Executive Officer - 2020-11-04
Director of Finance/CFO - 2014-03-06
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member - 2016-05-26
Chairman - 2020-11-04
Director/Board Member - 2020-01-16
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%-2.15%+0.29% - 158M
-0.89%-1.09%+19.16%+67.77% 48.26B
-1.72%-1.15%+45.80%+117.34% 40.5B
-0.70%-2.70%-10.84%+11.79% 11.85B
-2.01%-5.96%+10.47%+76.64% 11.83B
+2.31%0.00%+26.67%+153.33% 9.36B
+0.08%-4.11%+24.83%+43.80% 7.5B
-1.67%-0.35%+41.04%-11.59% 7.37B
-0.89%-3.09%+18.78%+207.82% 7.28B
-0.16%-2.36%-46.14%+16.28% 5.19B
Average -0.64%-2.09%+13.01%+75.91% 14.93B
Weighted average by Cap. -0.95%-1.71%+22.85%+82.78%

Financials

2024 2025
Net sales 8.92B 282M 243M 228M 208M 390M 26.62B 391M 2.7B 1.05B 13.66B 1.06B 1.04B 43.99B 8.57B 271M 233M 219M 200M 375M 25.58B 376M 2.59B 1.01B 13.12B 1.02B 995M 42.27B
Net income 317M 10.03M 8.63M 8.12M 7.42M 13.88M 947M 13.92M 95.96M 37.24M 486M 37.67M 36.84M 1.57B 300M 9.48M 8.16M 7.68M 7.01M 13.12M 895M 13.16M 90.74M 35.21M 459M 35.62M 34.84M 1.48B
Net Debt 2.46B 77.66M 66.83M 62.88M 57.44M 107M 7.33B 108M 743M 288M 3.76B 292M 285M 12.12B 2.26B 71.33M 61.38M 57.75M 52.75M 98.68M 6.73B 98.95M 682M 265M 3.46B 268M 262M 11.13B
Logo Cenra Inc.
Cenra Inc is a Taiwan-based company mainly engaged in the provision of general investment related businesses. Through its subsidiary, the Company conducts the development, manufacturing and sales of pharmaceuticals, agricultural and livestock drugs, personal hygiene and health products, as well as the import and sale of medical instruments. Its subsidiaries’ products are pharmaceuticals and health products, including human medicines, such as prescription and indicated drugs, over-the-counter medicines, and disease treatment products; medical equipment, such as blood pressure monitors, blood glucose meters, and artificial joints; animal medicines, supplementary feeds, and feed additives, providing animal treatment, disease prevention, and nutritional supplement products; daily necessities, such as toothpaste, tooth powder, mouthwash and other oral hygiene and health products, hand cleansers, dry hand sanitizers, shower gels, medicated soaps and lotion products, and skin care series.
Employees
-
Date Price Change Volume
26-09-04 NT$34.10 -0.73% 635,533
26-09-03 NT$34.35 -0.87% 327,035
26-09-02 NT$34.65 +0.14% 298,063
26-09-01 NT$34.60 -0.57% 263,319
26-08-31 NT$34.80 -0.14% 257,368
  1. Stock Market
  2. Stocks
  3. 3716 Stock